rel-MD Overview
- Year Founded
-
2011
- Status
-
Out of Business
- Employees
-
2
- Latest Deal Type
-
Out of Business
rel-MD General Information
Description
Developer of small molecule drugs. The company develops small molecule drugs to inhibit the rel proteins and offers treatment for cancer, inflammation and other diseases.
Contact Information
Website
www.relmd.comOwnership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
- 6411 Beckley Street
- Baltimore, MD 21224
- United States
+1 (443)
Corporate Office
- 6411 Beckley Street
- Baltimore, MD 21224
- United States
+1 (443)
rel-MD Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 01-Jan-2017 | Completed | Out of Business | |||
| 1. Early Stage VC | 10-Oct-2012 | Completed | Startup |
rel-MD Signals
rel-MD FAQs
-
When was rel-MD founded?
rel-MD was founded in 2011.
-
Where is rel-MD headquartered?
rel-MD is headquartered in Baltimore, MD.
-
What is the size of rel-MD?
rel-MD has 2 total employees.
-
What industry is rel-MD in?
rel-MD’s primary industry is Biotechnology.
-
Is rel-MD a private or public company?
rel-MD is a Private company.
-
What is rel-MD’s current revenue?
The current revenue for rel-MD is .
-
How much funding has rel-MD raised over time?
rel-MD has raised $46K.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process